DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Appeal No. 7035 of 2026 filed by Surajit Rout

SEBI 1 hr ago·9 Sept 2026, 12:30 pm

Company SEBI

Surajit Rout has filed an appeal against a court order, which could have significant implications for the company. This legal move suggests the company is challenging a previous decision, potentially altering its business trajectory or financial outlook. The outcome of this appeal remains uncertain, and its resolution will depend on the arguments presented and the court's ruling.

For investors, this development introduces a layer of uncertainty, as the appeal could affect the company's future performance or operational stability. While the current status is unclear, monitoring the progress of the case and any official statements from the company will be crucial. Investors should stay informed to understand how this legal battle might impact their investment decisions.